$KAYS
Kaya Holdings Inc Stock $kays

$kays Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000190359622000549 Filed on August 22, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$173.0K	$195.2K	$188.7K
YoY Change	-19.19%	-18.4%	-20.4%
Cost Of Revenue	$59.77K	$58.70K	$63.90K
YoY Change	-3.98%	-32.32%	-15.71%
Gross Profit	$113.2K	$136.5K	$124.8K
YoY Change	-25.43%	-10.48%	-22.61%
Gross Profit Margin	65.44%	69.93%	66.13%
Selling, General & Admin	$383.1K	$406.0K	$453.7K
YoY Change	-40.02%	-9.78%	-7.47%
% of Gross Profit	338.4%	297.47%	363.67%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$4.230K	$5.580K	$8.030K
YoY Change	-85.89%	-81.39%	-73.46%
% of Gross Profit	3.74%	4.09%	6.44%
Operating Expenses	$383.1K	$406.0K	$453.7K
YoY Change	-40.02%	-7.04%	-7.47%
Operating Profit	-$269.9K	-$269.5K	-$329.0K
YoY Change	-44.57%	-5.2%	-0.06%
Interest Expense	-$7.160M	$3.394M	-$769.0K
YoY Change	-264.66%	-63.82%	-85.24%
% of Operating Profit
Other Income/Expense, Net	-$7.143M	$3.394M	$0.00
YoY Change		-63.82%
Pretax Income	-$7.413M	$3.125M	-$1.098M
YoY Change	-288.44%	-65.65%	-80.06%
Income Tax	$22.54K	$54.86K	$0.00
% Of Pretax Income		1.76%
Net Earnings	-$7.415M	$3.103M	-$1.074M
YoY Change	-287.63%	-66.18%	-80.55%
Net Earnings / Revenue	-4286.86%	1590.0%	-569.16%
Basic Earnings Per Share
Diluted Earnings Per Share	-$503.6K	$41.13K	-$72.93K
COMMON SHARES
Basic Shares Outstanding	14.72M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$40.41K	$46.61K	$202.6K
YoY Change	-28.19%	-32.71%	186.26%
Cash & Equivalents	$40.41K	$46.61K	$566.0K
Short-Term Investments
Other Short-Term Assets	$13.97K	$13.97K	$13.97K
YoY Change	12.66%	16.71%	2.19%
Inventory	$28.71K	$39.67K	$41.78K
Prepaid Expenses	$13.97K	$13.97K
Receivables
Other Receivables
Total Short-Term Assets	$83.09K	$100.2K	$258.4K
YoY Change	-20.49%	-15.91%	76.44%
LONG-TERM ASSETS
Property, Plant & Equipment	$556.9K	$561.1K	$799.1K
YoY Change	-72.31%	-72.84%	-61.87%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$22.15K	$23.07K	$24.35K
YoY Change			-35.63%
Other Assets	$91.71K	$92.76K	$96.99K
YoY Change	10.04%	12.31%	487.46%
Total Long-Term Assets	$878.4K	$887.3K	$920.4K
YoY Change	-58.05%	-58.7%	-57.19%
TOTAL ASSETS
Total Short-Term Assets	$83.09K	$100.2K	$258.4K
Total Long-Term Assets	$878.4K	$887.3K	$920.4K
Total Assets	$961.5K	$987.5K	$1.179M
YoY Change	-56.27%	-56.45%	-48.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$148.4K	$158.9K	$1.041M
YoY Change	-93.38%	-92.34%	-46.25%
Accrued Expenses	$1.685M	$1.529M	$1.381M
YoY Change	50.18%	54.24%	58.43%
Deferred Revenue
YoY Change
Short-Term Debt	$9.310K	$9.310K	$9.310K
YoY Change	-97.99%	-96.41%	-96.41%
Long-Term Debt Due	$93.34K	$25.00K	$25.00K
YoY Change	-25.33%	-80.0%	-85.71%
Total Short-Term Liabilities	$12.88M	$5.441M	$8.769M
YoY Change	6.83%	-66.24%	-65.88%
LONG-TERM LIABILITIES
Long-Term Debt	$7.320M	$7.342M	$7.252M
YoY Change	8.05%	9.34%	7.43%
Other Long-Term Liabilities	$635.9K	$641.8K	$662.9K
YoY Change	213.67%	189.13%	175.71%
Total Long-Term Liabilities	$7.956M	$7.984M	$7.914M
YoY Change	14.03%	15.1%	13.22%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.88M	$5.441M	$8.769M
Total Long-Term Liabilities	$7.956M	$7.984M	$7.914M
Total Liabilities	$20.83M	$13.42M	$14.83M
YoY Change	19.57%	-37.45%	-52.42%
SHAREHOLDERS EQUITY
Retained Earnings	-$39.88M	-$32.47M
YoY Change
Common Stock	$14.72K	$14.72K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$17.96M	-$10.55M	-$13.66M
YoY Change
Total Liabilities & Shareholders Equity	$961.5K	$987.5K	$1.179M
YoY Change	-56.27%	-56.45%	-48.67%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$7.415M	$3.103M	-$1.074M
YoY Change	-287.63%	-66.18%	-80.55%
Depreciation, Depletion And Amortization	$4.230K	$5.580K	$8.030K
YoY Change	-85.89%	-81.39%	-73.46%
Cash From Operating Activities	-$173.4K	-$509.5K	-$361.6K
YoY Change	-1.56%	45.34%	71.2%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$17.18K	$0.00	$0.00
YoY Change	18.81%	-100.0%	-100.0%
Cash From Investing Activities	$17.18K
YoY Change	18.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00	$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	150.0K
YoY Change	-0.4%
NET CHANGE
Cash From Operating Activities	-173.4K	-$509.5K	-361.6K
Cash From Investing Activities	17.18K
Cash From Financing Activities	150.0K
Net Change In Cash	-6.200K	-$509.5K	$0.00
YoY Change	-43.94%	-1937.27%	-100.0%
FREE CASH FLOW
Cash From Operating Activities	-$173.4K	-$509.5K	-$361.6K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss		usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001530746
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2022Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021Q2	kays	Net Loss Attirbuted To Noncontrolling Interest NetLossAttirbutedToNoncontrollingInterest		usd
	kays	Net Loss Attirbuted To Noncontrolling Interest NetLossAttirbutedToNoncontrollingInterest		usd
CY2022Q2	kays	Loss Gain On Impairment Of Rightofuse Asset LossGainOnImpairmentOfRightofuseAsset		usd
CY2022Q2	us-gaap	Derivative Cost Of Hedge DerivativeCostOfHedge		usd
CY2022Q2	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2021Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022Q2	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2022Q2	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2021Q2	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022Q2	kays	Reclassification Of Derivative Liabilities To Additional Paid In Capital ReclassificationOfDerivativeLiabilitiesToAdditionalPaidInCapital		usd
CY2022Q2	kays	Derivative Liability On Convertible Note Payable DerivativeLiabilityOnConvertibleNotePayable		usd
CY2022Q2	kays	Value Of Common Shares Issued For Conversion Of Principle And Interest ValueOfCommonSharesIssuedForConversionOfPrincipleAndInterest		usd
CY2022Q2	kays	Capitalization Of Interest Pursuant To Amended Agreement CapitalizationOfInterestPursuantToAmendedAgreement		usd
CY2022Q2	kays	Shares Issued For Cash From Stock Payable SharesIssuedForCashFromStockPayable		usd
CY2021	kays	Share Cancellation ShareCancellation		usd
CY2021	kays	Exchange Of Pre Of Preferred Shares Series C To Series D ExchangeOfPreOfPreferredSharesSeriesCToSeriesD		usd
CY2022Q2	kays	Structural Structural		usd
CY2021Q4	kays	Structural Structural		usd
CY2021Q4	us-gaap	Other Receivables OtherReceivables		usd
	kays	Conversion Of Debtreclas To Apic ConversionOfDebtreclasToApic		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Entity File Number EntityFileNumber	333-177532
	dei	Entity Registrant Name EntityRegistrantName	KAYA HOLDINGS, INC
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-0898007
	dei	Entity Address Address Line1 EntityAddressAddressLine1	915 Middle River Drive
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 316
	dei	Entity Address City Or Town EntityAddressCityOrTown	Ft. Lauderdale
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33304
	dei	City Area Code CityAreaCode	954
	dei	Local Phone Number LocalPhoneNumber	892-6911
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	14722835	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46605	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	565979	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	39668	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	51484	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	13967	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	13967	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	100240	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	631430	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	210326	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	255770	usd
CY2022Q2	us-gaap	Property Plant And Equipment Owned Accumulated Depreciation PropertyPlantAndEquipmentOwnedAccumulatedDepreciation	377942	usd
CY2021Q4	us-gaap	Property Plant And Equipment Owned Accumulated Depreciation PropertyPlantAndEquipmentOwnedAccumulatedDepreciation	364331	usd
CY2022Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	561122	usd
CY2021Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	574733	usd
CY2022Q2	kays	Investment In Subsidaries InvestmentInSubsidaries	23067	usd
CY2021Q4	kays	Investment In Subsidaries InvestmentInSubsidaries	25021	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	92760	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	82159	usd
CY2022Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	887275	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	937683	usd
CY2022Q2	us-gaap	Assets Assets	987515	usd
CY2021Q4	us-gaap	Assets Assets	1569113	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	922308	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	918148	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Fair Value Disclosure AccountsPayableAndAccruedLiabilitiesFairValueDisclosure	227012	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Fair Value Disclosure AccountsPayableAndAccruedLiabilitiesFairValueDisclosure	141990	usd
CY2022Q2	us-gaap	Interest Payable Current InterestPayableCurrent	1449064	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1152783	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	80172	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	79875	usd
CY2022Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	836970	usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	782107	usd
CY2022Q2	kays	Convertible Notes Payable Related Party Net Of Discount ConvertibleNotesPayableRelatedPartyNetOfDiscount	0	usd
CY2021Q4	kays	Convertible Notes Payable Related Party Net Of Discount ConvertibleNotesPayableRelatedPartyNetOfDiscount	0	usd
CY2022Q2	kays	Convertible Notes Payable Net Of Discount Current ConvertibleNotesPayableNetOfDiscountCurrent	25000	usd
CY2021Q4	kays	Convertible Notes Payable Net Of Discount Current ConvertibleNotesPayableNetOfDiscountCurrent	25000	usd
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent	9312	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	9312	usd
CY2022Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1890741	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	4980563	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5440579	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8089778	usd
CY2022Q2	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	250000	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	250000	usd
CY2022Q2	kays	Convertible Notes Payable Long Term Net Of Discount ConvertibleNotesPayableLongTermNetOfDiscount	320430	usd
CY2021Q4	kays	Convertible Notes Payable Long Term Net Of Discount ConvertibleNotesPayableLongTermNetOfDiscount	477634	usd
CY2022Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	7091722	usd
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	6934518	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	500000	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	500000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	141794	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	202722	usd
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	7983516	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	7887240	usd
CY2022Q2	us-gaap	Liabilities Liabilities	13424095	usd
CY2021Q4	us-gaap	Liabilities Liabilities	15977018	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14722835	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14722835	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14722835	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14722835	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	14723	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	14723	usd
CY2022Q2	us-gaap	Preferred Stock Shares Subscribed But Unissued Value PreferredStockSharesSubscribedButUnissuedValue	163630	usd
CY2021Q4	us-gaap	Preferred Stock Shares Subscribed But Unissued Value PreferredStockSharesSubscribedButUnissuedValue	163630	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	21746395	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	21735185	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-32465658	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34495346	usd
CY2022Q2	kays	Accumulated Other Comprehensive Income AccumulatedOtherComprehensiveIncome	-9688	usd
CY2021Q4	kays	Accumulated Other Comprehensive Income AccumulatedOtherComprehensiveIncome	-3719	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-10550598	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-12585527	usd
CY2022Q2	us-gaap	Minority Interest MinorityInterest	-1885982	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	-1822378	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-12436580	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-14407905	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	987515	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1569113	usd
CY2022Q2	us-gaap	Revenues Revenues	195186	usd
CY2021Q2	us-gaap	Revenues Revenues	239198	usd
	us-gaap	Revenues Revenues	383850	usd
	us-gaap	Revenues Revenues	476216	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	58698	usd
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	86729	usd
	us-gaap	Cost Of Revenue CostOfRevenue	122598	usd
	us-gaap	Cost Of Revenue CostOfRevenue	162543	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	136488	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	152469	usd
	us-gaap	Gross Profit GrossProfit	261252	usd
	us-gaap	Gross Profit GrossProfit	313673	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	182633	usd
CY2021Q2	us-gaap	Professional Fees ProfessionalFees	158191	usd
	us-gaap	Professional Fees ProfessionalFees	383389	usd
	us-gaap	Professional Fees ProfessionalFees	365905	usd
CY2022Q2	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	102873	usd
CY2021Q2	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	87638	usd
	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	202151	usd
	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	174621	usd
CY2021Q2	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	-13259	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	-44930	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	120501	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	204198	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	274175	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	399848	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	406007	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	436768	usd
	us-gaap	Operating Expenses OperatingExpenses	859715	usd
	us-gaap	Operating Expenses OperatingExpenses	895444	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-269519	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-284299	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-598463	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-581771	usd
CY2022Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	154570	usd
CY2021Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	160961	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	307439	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	310820	usd
CY2022Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	90122	usd
CY2021Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	70094	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	157204	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	213071	usd
CY2021Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-186017	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-566080	usd
CY2022Q2	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Other Comprehensive Income Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss	3638827	usd
CY2021Q2	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Other Comprehensive Income Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss	9798331	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Other Comprehensive Income Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss	3089822	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Other Comprehensive Income Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss	5262894	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3394135	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	9381259	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2625179	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4172923	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	3124616	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	9096960	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	2026716	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	3591152	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	54863	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	54863	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	3069753	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	9096960	usd
	us-gaap	Profit Loss ProfitLoss	1971853	usd
	us-gaap	Profit Loss ProfitLoss	3591152	usd
CY2022Q2	us-gaap	Net Income Loss From Real Estate Investment Partnership Attributable To Noncontrolling Interest NetIncomeLossFromRealEstateInvestmentPartnershipAttributableToNoncontrollingInterest	-33711	usd
CY2021Q2	us-gaap	Net Income Loss From Real Estate Investment Partnership Attributable To Noncontrolling Interest NetIncomeLossFromRealEstateInvestmentPartnershipAttributableToNoncontrollingInterest	-79853	usd
	us-gaap	Net Income Loss From Real Estate Investment Partnership Attributable To Noncontrolling Interest NetIncomeLossFromRealEstateInvestmentPartnershipAttributableToNoncontrollingInterest	-57835	usd
	us-gaap	Net Income Loss From Real Estate Investment Partnership Attributable To Noncontrolling Interest NetIncomeLossFromRealEstateInvestmentPartnershipAttributableToNoncontrollingInterest	-65453	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	3103464	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	9176813	usd
	us-gaap	Net Income Loss NetIncomeLoss	2029688	usd
	us-gaap	Net Income Loss NetIncomeLoss	3656605	usd
CY2022Q2	kays	Basic Net Loss Per Common Share BasicNetLossPerCommonShare	0.21
CY2021Q2	kays	Basic Net Loss Per Common Share BasicNetLossPerCommonShare	0.61
	kays	Basic Net Loss Per Common Share BasicNetLossPerCommonShare	0.14
	kays	Basic Net Loss Per Common Share BasicNetLossPerCommonShare	0.24
CY2022Q2	kays	Weighted Average Number Of Common Shares Outstanding Basic WeightedAverageNumberOfCommonSharesOutstandingBasic	14722835	shares
CY2021Q2	kays	Weighted Average Number Of Common Shares Outstanding Basic WeightedAverageNumberOfCommonSharesOutstandingBasic	15006625	shares
	kays	Weighted Average Number Of Common Shares Outstanding Basic WeightedAverageNumberOfCommonSharesOutstandingBasic	14722835	shares
	kays	Weighted Average Number Of Common Shares Outstanding Basic WeightedAverageNumberOfCommonSharesOutstandingBasic	14650881	shares
CY2022Q2	kays	Diluted Net Income Loss Per Common Share DilutedNetIncomeLossPerCommonShare	0.04
CY2021Q2	kays	Diluted Net Income Loss Per Common Share DilutedNetIncomeLossPerCommonShare	0.13
	kays	Diluted Net Income Loss Per Common Share DilutedNetIncomeLossPerCommonShare	0.03
	kays	Diluted Net Income Loss Per Common Share DilutedNetIncomeLossPerCommonShare	0.05
CY2022Q2	kays	Weighted Average Number Of Common Shares Outstanding Diluted WeightedAverageNumberOfCommonSharesOutstandingDiluted	75458842	shares
CY2021Q2	kays	Weighted Average Number Of Common Shares Outstanding Diluted WeightedAverageNumberOfCommonSharesOutstandingDiluted	70174904	shares
	kays	Weighted Average Number Of Common Shares Outstanding Diluted WeightedAverageNumberOfCommonSharesOutstandingDiluted	75458842	shares
	kays	Weighted Average Number Of Common Shares Outstanding Diluted WeightedAverageNumberOfCommonSharesOutstandingDiluted	69819160	shares
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	3103464	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	9176813	usd
	us-gaap	Net Income Loss NetIncomeLoss	2029688	usd
	us-gaap	Net Income Loss NetIncomeLoss	3656605	usd
CY2022Q2	kays	Foreign Currency Adjustments ForeignCurrencyAdjustments	-7582	usd
CY2021Q2	kays	Foreign Currency Adjustments ForeignCurrencyAdjustments	-1619	usd
	kays	Foreign Currency Adjustments ForeignCurrencyAdjustments	-11738	usd
	kays	Foreign Currency Adjustments ForeignCurrencyAdjustments	-1619	usd
CY2022Q2	kays	Comprehensive Income Loss ComprehensiveIncomeLoss	3095882	usd
CY2021Q2	kays	Comprehensive Income Loss ComprehensiveIncomeLoss	9175194	usd
	kays	Comprehensive Income Loss ComprehensiveIncomeLoss	2017950	usd
	kays	Comprehensive Income Loss ComprehensiveIncomeLoss	3654986	usd
CY2022Q2	kays	Net Loss Attirbuted To Noncontrolling Interest NetLossAttirbutedToNoncontrollingInterest	37371	usd
	kays	Net Loss Attirbuted To Noncontrolling Interest NetLossAttirbutedToNoncontrollingInterest	63603	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	3133251	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	9175194	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	2075785	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	3654986	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2029688	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3656605	usd
CY2022Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest	-57835	usd
CY2021Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest	-65453	usd
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	13611	usd
CY2021Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	60241	usd
CY2022Q2	kays	Imputed Interests ImputedInterests	11158	usd
CY2021Q2	kays	Imputed Interests ImputedInterests	11096	usd
CY2021Q2	kays	Loss Gain On Impairment Of Rightofuse Asset LossGainOnImpairmentOfRightofuseAsset	-45035	usd
CY2021Q2	us-gaap	Derivative Cost Of Hedge DerivativeCostOfHedge	566080	usd
CY2022Q2	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	3089822	usd
CY2021Q2	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	5262894	usd
CY2022Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	157204	usd
CY2021Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	213071	usd
CY2021Q2	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-168	usd
CY2022Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-11816	usd
CY2021Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-9662	usd
CY2022Q2	kays	Rightofuse Asset1 RightofuseAsset1	-45444	usd
CY2021Q2	kays	Rightofuse Asset1 RightofuseAsset1	-21775	usd
CY2022Q2	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	10485	usd
CY2021Q2	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	34392	usd
CY2022Q2	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	296281	usd
CY2021Q2	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	299724	usd
CY2022Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4160	usd
CY2021Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	105559	usd
CY2022Q2	kays	Accounts Payable And Accrued Expenses Related Parties AccountsPayableAndAccruedExpensesRelatedParties	85074	usd
CY2021Q2	kays	Accounts Payable And Accrued Expenses Related Parties AccountsPayableAndAccruedExpensesRelatedParties	134606	usd
CY2022Q2	kays	Rightofuse Liabilities1 RightofuseLiabilities1	-60631	usd
CY2021Q2	kays	Rightofuse Liabilities1 RightofuseLiabilities1	-21355	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-509474	usd
CY2021Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-350543	usd
CY2021Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	35000	usd
CY2021Q2	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	316000	usd
CY2021Q2	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	27273	usd
CY2021Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	378273	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-509474	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	27731	usd
CY2022Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-9900	usd
CY2021Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1619	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	565979	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	43162	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	46605	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	69274	usd
CY2021Q2	kays	Reclassification Of Derivative Liabilities To Additional Paid In Capital ReclassificationOfDerivativeLiabilitiesToAdditionalPaidInCapital	283326	usd
CY2021Q2	kays	Derivative Liability On Convertible Note Payable DerivativeLiabilityOnConvertibleNotePayable	316000	usd
CY2021Q2	kays	Value Of Common Shares Issued For Conversion Of Principle And Interest ValueOfCommonSharesIssuedForConversionOfPrincipleAndInterest	196015	usd
CY2021Q2	kays	Capitalization Of Interest Pursuant To Amended Agreement CapitalizationOfInterestPursuantToAmendedAgreement	18992	usd
CY2021Q2	kays	Shares Issued For Cash From Stock Payable SharesIssuedForCashFromStockPayable	250	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-24926089	usd
CY2021	kays	Imputed Interest ImputedInterest	22438	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	35000	usd
CY2021	kays	Common Stock Issued For Notes Conversion And Interest CommonStockIssuedForNotesConversionAndInterest	196015	usd
CY2021	kays	Settlement Of Related Party Accrued Compensation SettlementOfRelatedPartyAccruedCompensation	559058	usd
CY2021	kays	Reclassification Of Derivative Liabilities To Additional Paid In Capital ReclassificationOfDerivativeLiabilitiesToAdditionalPaidInCapital	283326	usd
CY2021	kays	Business Combination Of Foreign Entities BusinessCombinationOfForeignEntities	35805	usd
CY2021	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-6711	usd
CY2021	us-gaap	Profit Loss ProfitLoss	9393253	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-14407905	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-14407905	usd
	kays	Imputed Interest ImputedInterest	11158	usd
	kays	Settlement Of Related Party Accrued Compensation SettlementOfRelatedPartyAccruedCompensation	52	usd
	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-11738	usd
	us-gaap	Profit Loss ProfitLoss	1971853	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-12436580	usd
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-2029688	usd
CY2021	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-3656605	usd
CY2022Q2	kays	Working Capital Deficiency WorkingCapitalDeficiency	5272239	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_841_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z1ECM9vsdedk" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zPRApUEihyVi">Reclassifications</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior period amounts have been reclassified to conform to the current period presentation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_840_eus-gaap--UseOfEstimates_zhFC66Ca3c0g" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zfHHiPjqpJJ">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such estimates and assumptions impact both assets and liabilities, including but not limited to: net realizable value of accounts receivable and inventory, estimated useful lives and potential impairment of property and equipment, the valuation of intangible assets, estimate of fair value of share based payments and derivative liabilities, estimates of fair value of warrants issued and recorded as debt discount, estimates of tax liabilities and estimates of the probability and potential magnitude of contingent liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future non-conforming events. Accordingly, actual results could differ significantly from estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zE3fY5oIFLT2" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zw5JVrUopm4c">Risks and Uncertainties</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s operations are subject to risk and uncertainties including financial, operational, regulatory and other risks including the potential risk of business failure. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has experienced, and in the future expects to continue to experience, variability in its sales and earnings. The factors expected to contribute to this variability include, among others, (i) the uncertainty associated with the commercialization and ultimate success of the product, (ii) competition inherent at other locations where product is expected to be sold (iii) general economic conditions and (iv) the related volatility of prices pertaining to the cost of sales. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Fiscal Period FiscalPeriod	<p id="xdx_841_eus-gaap--FiscalPeriod_ztRqwdfL4B51" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zsS48s2QrAEk">Fiscal Year</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s fiscal year-end is December 31.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	39668	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	51484	usd
CY2022Q2	us-gaap	Inventory Finished Homes InventoryFinishedHomes	0	usd
CY2021Q4	us-gaap	Inventory Finished Homes InventoryFinishedHomes	0	usd
	us-gaap	Revenue Recognition Leases Operating RevenueRecognitionLeasesOperating	<p id="xdx_841_eus-gaap--RevenueRecognitionLeasesOperating_zqBaV3qp2T01" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zCnhdnB3alV9">Operating Leases</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We lease our retail stores under non-cancellable operating leases. Most store leases include tenant allowances from landlords, rent escalation clauses and/or contingent rent provisions. We recognize rent expense on a straight-line basis over the lease term, excluding contingent rent, and record the difference between the amount charged to expense and the rent paid as a deferred rent liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	782107	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<p id="xdx_846_eus-gaap--DerivativesReportingOfDerivativeActivity_zohkYyctcHE4" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zYr6jENKcU3b">Derivative Financial Instruments</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of it financial instruments, including stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported as charges or credits to income. For option-based simple derivative financial instruments, the Company uses the Binomial option-pricing model to value the derivative instruments at inception and subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In July 2017, the FASB issued ASU 2017-11 <i>Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivative and Hedging (Topic 815).</i> The amendments in Part I of this Update change the classification analysis of certain equity-linked financial instruments (or embedded features) with down round features. When determining whether certain financial instruments should be classified as liabilities or equity instruments, a down round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity’s own stock. The amendment also clarifies existing disclosure requirements for equity-classified instruments. As a result, a freestanding equity-linked financial instrument (or embedded conversion option) no longer would be accounted for as a derivative liability at fair value as a result of the existence of a down round feature. For freestanding equity classified financial instruments, the amendments require entities that present earnings per share (“EPS”) in accordance with Topic 260 to recognize the effect of the down round feature when it is triggered. That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. Convertible instruments with embedded conversion options that have down round features are now subject to the specialized guidance for contingent beneficial conversion features (in Subtopic 470-20, Debt-Debt with Conversion and Other Options), including related EPS guidance (in Topic 260). The amendments in Part II of this Update recharacterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the Codification, to a scope exception. Those amendments do not have an accounting effect.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior to this Update, an equity-linked financial instrument with a down round feature that otherwise is not required to be classified as a liability under the guidance in Topic 480 is evaluated under the guidance in Topic 815, Derivatives and Hedging, to determine whether it meets the definition of a derivative. If it meets that definition, the instrument (or embedded feature) is evaluated to determine whether it is indexed to an entity’s own stock as part of the analysis of whether it qualifies for a scope exception from derivative accounting. Generally, for warrants and conversion options embedded in financial instruments that are deemed to have a debt host (assuming the underlying shares are readily convertible to cash or the contract provides for net settlement such that the embedded conversion option meets the definition of a derivative), the existence of a down round feature results in an instrument not being considered indexed to an entity’s own stock. This results in a reporting entity being required to classify the freestanding financial instrument or the bifurcated conversion option as a liability, which the entity must measure at fair value initially and at each subsequent reporting date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amendments in this Update revise the guidance for instruments with down round features in Subtopic 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity, which is considered in determining whether an equity-linked financial instrument qualifies for a scope exception from derivative accounting. An entity still is required to determine whether instruments would be classified in equity under the guidance in Subtopic 815-40 in determining whether they qualify for that scope exception. If they do qualify, freestanding instruments with down round features are no longer classified as liabilities and embedded conversion options with down round features are no longer bifurcated.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For entities that present EPS in accordance with Topic 260, and when the down round feature is included in an equity-classified freestanding financial instrument, the value of the effect of the down round feature is treated as a dividend when it is triggered and as a numerator adjustment in the basic EPS calculation. This reflects the occurrence of an economic transfer of value to the holder of the instrument, while alleviating the complexity and income statement volatility associated with fair value measurement on an ongoing basis. Convertible instruments are unaffected by the Topic 260 amendments in this Update.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amendments in Part 1 of this Update are a cost savings relative to former accounting. This is because, assuming the required criteria for equity classification in Subtopic 815-40 are met, an entity that issued such an instrument no longer measures the instrument at fair value at each reporting period (in the case of warrants) or separately accounts for a bifurcated derivative (in the case of convertible instruments) on the basis of the existence of a down round feature. For convertible instruments with embedded conversion options that have down round features, applying specialized guidance such as the model for contingent beneficial conversion features rather than bifurcating an embedded derivative also reduces cost and complexity. Under that specialized guidance, the issuer recognizes the intrinsic value of the feature only when the feature becomes beneficial instead of bifurcating the conversion option and measuring it at fair value each reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amendments in Part II of this Update replace the indefinite deferral of certain guidance in Topic 480 with a scope exception. This has the benefit of improving the readability of the Codification and reducing the complexity associated with navigating the guidance in Topic 480.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company adopted this new standard on January 1, 2019; however, the Company needs to continue the derivative liabilities due to variable conversion price on some of the convertible instruments. As such, it did not have a material impact on the Company’s consolidated financial statements. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2021Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	42965	usd
CY2022Q2	kays	Hvac Hvac	44430	usd
CY2021Q4	kays	Hvac Hvac	44430	usd
CY2022Q2	kays	Atm Machine1 AtmMachine1	5600	usd
CY2021Q4	kays	Atm Machine1 AtmMachine1	5600	usd
CY2022Q2	kays	Computer1 Computer1	30713	usd
CY2021Q4	kays	Computer1 Computer1	30713	usd
CY2022Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	42965	usd
CY2022Q2	us-gaap	Land Land	533778	usd
CY2021Q4	us-gaap	Land Land	533778	usd
CY2022Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	147636	usd
CY2021Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	147636	usd
CY2022Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	69312	usd
CY2021Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	69312	usd
CY2022Q2	kays	Sign Sign	12758	usd
CY2021Q4	kays	Sign Sign	12758	usd
CY2022Q2	kays	Vehicle Vehicle	51872	usd
CY2021Q4	kays	Vehicle Vehicle	51872	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	939064	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	939064	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	377942	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	364331	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	561122	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	574733	usd
	us-gaap	Depreciation Depreciation	13611	usd
	us-gaap	Depreciation Depreciation	60242	usd
CY2020Q4	us-gaap	Assets Net AssetsNet	173658	usd
CY2020	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	173658	usd
CY2022Q2	us-gaap	Other Receivables OtherReceivables	10485	usd
CY2022Q2	kays	Rent Deposits RentDeposits	11016	usd
CY2021Q4	kays	Rent Deposits RentDeposits	11016	usd
CY2022Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	71259	usd
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	71143	usd
CY2022Q2	us-gaap	Noncurrent Assets NoncurrentAssets	92760	usd
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	82159	usd
CY2022Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1890741	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	4980563	usd
CY2022Q2	kays	Total Convertible Debt TotalConvertibleDebt	7437152	usd
CY2021Q4	kays	Total Convertible Debt TotalConvertibleDebt	7437152	usd
CY2022Q2	kays	Convertible Notes Payable Long Term Net Of Discounts ConvertibleNotesPayableLongTermNetOfDiscounts	-320430	usd
CY2021Q4	kays	Convertible Notes Payable Long Term Net Of Discounts ConvertibleNotesPayableLongTermNetOfDiscounts	-477634	usd
CY2022Q2	kays	Convertible Notes Payable Net Of Discount ConvertibleNotesPayableNetOfDiscount	7116722	usd
CY2021Q4	kays	Convertible Notes Payable Net Of Discount ConvertibleNotesPayableNetOfDiscount	6959518	usd
CY2022Q2	kays	Convertible Debt Net Of Discounts Current ConvertibleDebtNetOfDiscountsCurrent	25000	usd
CY2021Q4	kays	Convertible Debt Net Of Discounts Current ConvertibleDebtNetOfDiscountsCurrent	25000	usd
CY2022Q2	us-gaap	Convertible Debt ConvertibleDebt	7091722	usd
CY2021Q4	us-gaap	Convertible Debt ConvertibleDebt	6934518	usd
CY2022Q2	us-gaap	Due To Other Related Parties Noncurrent DueToOtherRelatedPartiesNoncurrent	9312	usd
CY2021Q4	us-gaap	Due To Other Related Parties Noncurrent DueToOtherRelatedPartiesNoncurrent	9312	usd
CY2022Q2	us-gaap	Loans Payable LoansPayable	250000	usd
CY2021Q4	us-gaap	Loans Payable LoansPayable	250000	usd
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14722835	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14722835	shares
	kays	Derivative Liabilities Text Bock DerivativeLiabilitiesTextBock	<p id="xdx_80E_ecustom--DerivativeLiabilitiesTextBock_z9S93iaqJu7f" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9 <span id="xdx_824_zBhs7ideVLBi">DERIVATIVE LIABILITIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective January 1, 2019, an equity-linked financial instrument with a down round feature that otherwise is not required to be classified as a liability under the guidance in Topic 480 is evaluated under the guidance in Topic 815, Derivatives and Hedging, to determine whether it meets the definition of a derivative. If it meets that definition, the instrument (or embedded feature) is evaluated to determine whether it is indexed to an entity’s own stock as part of the analysis of whether it qualifies for a scope exception from derivative accounting. Generally, for warrants and conversion options embedded in financial instruments that are deemed to have a debt host (assuming the underlying shares are readily convertible to cash or the contract provides for net settlement such that the embedded conversion option meets the definition of a derivative), the existence of a down round feature results in an instrument not being considered indexed to an entity’s own stock. This results in a reporting entity being required to classify the freestanding financial instrument or the bifurcated conversion option as a liability, which the entity must measure at fair value initially and at each subsequent reporting date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However, due to a recognition of tainting, due to variable conversion price on some of the convertible notes, all convertible notes are considered to have a derivative liability, therefore the Company accounted for these Notes under ASC Topic 815-15 “Embedded Derivative.” The derivative component of the obligation is initially valued and classified as a derivative liability with an offset to discounts on convertible debt. Discounts are amortized to interest expense over the respective term of the related note. In determining the indicated value of the convertible note issued, the Company used the Binomial Options Pricing Model with a risk-free interest rate of ranging from 2.51% to 2.92%, volatility ranging from 151.36% to 151.36%, trading prices ranging from $0.06 per share to $0.06 per share and a conversion price ranging from $0.15 per share. The total derivative liabilities associated with these notes were $1,890,741 at June 30, 2022 and $4,980,563 at December 31, 2021</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of the application of ASC No. 815, the fair value of the ratchet feature related to convertible debt and warrants is summarized as follow: </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zkepUUiISnR1" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - DERIVATIVE LIABILITIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_8BC_zsjzZCPs48Y8" style="display: none">Schedule of Derivative liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 70%; text-align: justify">Balance as of December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--DerivativeLiabilities_iS_pp0p0_c20220101__20220630_zrPVCdpktda7" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Balance at beginning">4,980,563</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Initial</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_ecustom--InitialDerivativeLiabilities_pp0p0_d0_c20220101__20220630_z2KvPW4qgVtb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Initial">— </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Change in Derivative Values</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_ecustom--ChangeInDerivativeLiabilities_c20220101__20220630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in Derivative Liabilities">(3,089,822</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt">Conversion of debt-reclass to APIC</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_ecustom--ConversionOfDebtreclasToApic_c20220101__20220630_pp0p0" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Conversion Of Debtreclas To Apic"><span style="-sec-ix-hidden: xdx2ixbrl1350">—</span> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Balance as of June 30, 2022</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--DerivativeLiabilities_iE_pp0p0_c20220101__20220630_zLSC0zS08kRd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance at ending">1,890,741</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recorded the debt discount to the extent of the gross proceeds raised and expensed immediately the remaining fair value of the derivative liability, as it exceeded the gross proceeds of the note. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recoded initial derivative liabilities of $<span id="xdx_90C_ecustom--InitialDerivativeLiabilities_c20220101__20220630_pp0p0" title="Initial derivative liabilities">0</span> and $<span id="xdx_907_ecustom--InitialDerivativeLiabilities_c20210101__20211231_pp0p0" title="Initial derivative liabilities">882,080</span> for the new notes issued for six months ended June 3, 2022 and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recorded derivative liability expense of $<span id="xdx_909_ecustom--DerivativeLiabilityExpense_c20220101__20220630_pp0p0" title="Derivative liability expense">0</span> and $<span id="xdx_90D_ecustom--DerivativeLiabilityExpense_c20210101__20211231_pp0p0" title="Derivative liability expense">566,080</span> for the six months ended June 30, 2022 and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recorded a change in the value of embedded derivative liabilities expense of $<span id="xdx_90B_ecustom--ChangeInValueOfEmbeddedDerivativeLiabilitiesExpense_c20220101__20220630_pp0p0" title="Change in value of embedded derivative liabilities expense">(3,089,822</span>) and $<span id="xdx_907_ecustom--ChangeInValueOfEmbeddedDerivativeLiabilitiesExpense_c20210101__20211231_pp0p0" title="Change in value of embedded derivative liabilities expense">5,262,894</span> for the three months ended June 30, 2022 and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	4980563	usd
	kays	Initial Derivative Liabilities InitialDerivativeLiabilities	0	usd
	kays	Change In Derivative Liabilities ChangeInDerivativeLiabilities	-3089822	usd
CY2022Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	1890741	usd
	kays	Initial Derivative Liabilities InitialDerivativeLiabilities	0	usd
CY2021	kays	Initial Derivative Liabilities InitialDerivativeLiabilities	882080	usd
	kays	Derivative Liability Expense DerivativeLiabilityExpense	0	usd
CY2021	kays	Derivative Liability Expense DerivativeLiabilityExpense	566080	usd
	kays	Change In Value Of Embedded Derivative Liabilities Expense ChangeInValueOfEmbeddedDerivativeLiabilitiesExpense	-3089822	usd
CY2021	kays	Change In Value Of Embedded Derivative Liabilities Expense ChangeInValueOfEmbeddedDerivativeLiabilitiesExpense	5262894	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	320430	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	597859	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	157204	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	213071	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	158912	usd
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	754369	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.4744455
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y1M2D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	16667	shares
CY2022Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	737703	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.4744455
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y5M23D
CY2022Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0932	pure
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	210326	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	141794	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	47475	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	106544	usd
CY2022Q2	us-gaap	Capital Leases Future Minimum Payments Next Rolling Twelve Months CapitalLeasesFutureMinimumPaymentsNextRollingTwelveMonths	48539	usd
CY2022Q2	us-gaap	Capital Leases Future Minimum Payments Due In Rolling Year Two CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo	99203	usd
CY2022Q2	us-gaap	Capital Leases Future Minimum Payments Due In Rolling Year Three CapitalLeasesFutureMinimumPaymentsDueInRollingYearThree	76617	usd
CY2022Q2	us-gaap	Capital Leases Future Minimum Payments Due In Rolling After Year Five CapitalLeasesFutureMinimumPaymentsDueInRollingAfterYearFive	27041	usd
CY2022Q2	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	251399	usd
CY2022Q2	kays	Less Imputed Interest LessImputedInterest	-29433	usd
CY2022Q2	kays	Present Value Of Lease Liabilities PresentValueOfLeaseLiabilities	221967	usd

Files In Submission

Name	View Source	Status
0001903596-22-000549-index-headers.html	Edgar Link	pending
0001903596-22-000549-index.html	Edgar Link	pending
0001903596-22-000549.txt	Edgar Link	pending
0001903596-22-000549-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_006.jpg	Edgar Link	pending
image_007.jpg	Edgar Link	pending
image_008.jpg	Edgar Link	pending
image_009.jpg	Edgar Link	pending
image_010.jpg	Edgar Link	pending
image_011.jpg	Edgar Link	pending
image_012.jpg	Edgar Link	pending
image_013.jpg	Edgar Link	pending
image_014.jpg	Edgar Link	pending
image_015.jpg	Edgar Link	pending
image_016.jpg	Edgar Link	pending
image_017.jpg	Edgar Link	pending
image_018.jpg	Edgar Link	pending
image_019.jpg	Edgar Link	pending
image_020.jpg	Edgar Link	pending
image_021.jpg	Edgar Link	pending
image_022.jpg	Edgar Link	pending
image_023.jpg	Edgar Link	pending
image_024.jpg	Edgar Link	pending
image_025.jpg	Edgar Link	pending
image_026.jpg	Edgar Link	pending
image_027.jpg	Edgar Link	pending
image_028.jpg	Edgar Link	pending
image_029.jpg	Edgar Link	pending
image_030.jpg	Edgar Link	pending
image_031.jpg	Edgar Link	pending
image_032.jpg	Edgar Link	pending
kays-20220630.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
kays-20220630_cal.xml	Edgar Link	unprocessable
kays-20220630_lab.xml	Edgar Link	unprocessable
kays-20220630_pre.xml	Edgar Link	unprocessable
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sfskays10q081722.htm	Edgar Link	pending
sfskays10q081722ex31_1.htm	Edgar Link	pending
sfskays10q081722ex32_1.htm	Edgar Link	pending
Show.js	Edgar Link	pending
sfskays10q081722_htm.xml	Edgar Link	completed
kays-20220630_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KAYS
Kaya Holdings Inc Stock $kays

2022 Q3 Form 10-Q Financial Statement

#000190359622000549 Filed on August 22, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KAYS Kaya Holdings Inc Stock $kays

2022 Q3 Form 10-Q Financial Statement

#000190359622000549 Filed on August 22, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KAYS
Kaya Holdings Inc Stock $kays